Lidocaine/ Fluorescein
Indications
Registered South African indications:
- Ophthalmic diagnosis
- Local anaesthesia
Cautions
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
- Hypersensitivity to amide-type local anaesthetics
Cautions
- Pregnancy
- Renal impairment
- Hepatic impairment
- Use in an inflamed eye
Adult dosage
Forms avail. in SA and covered in this monograph: opd
Combined diagnostic stain and topical anaesthetic
Lidocaine/ Fluorescein
20/1.25 (mg/0.5ml)
- Ophthalmic (opd): 1 or more drops, as directed by ophthalmologist
Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: opd
Combined diagnostic stain and topical anaesthetic
Lidocaine/ Fluorescein
20/1.25 (mg/0.5ml)
- Ophthalmic (opd): As directed by ophthalmologist
Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Skin and Subcutaneous Tissue Disorders
- Urticaria
- Rash
Immune, Blood and Lymphatic System Disorders
- Anaphylactic reaction
Sensory Disorders
- Allergic conjunctivitis
- Peri-orbital oedema
Interactions
No information available
Monitoring
None routine
Mechanism of action
Lidocaine
Lidocaine inhibits the ionic refluxes required for the initiation and conduction of impulses, thereby stabilising the neuronal membrane. After absorption, lidocaine may cause stimulation of the central nervous system followed by depression, and in the cardiovascular system, it acts primarily on the myocardium where it may produce a decrease in electrical excitability, conduction rate and force of contraction. Lidocaine causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane.
Fluorescein
Fluorescein sodium is used as an ophthalmologic diagnostic tool for corneal abrasions, corneal ulcers, herpetic corneal infections, and dry eye. Fluorescein does not stain a normal cornea but conjunctival abrasions are stained yellow or orange, corneal abrasions or ulcers are stained a bright green and foreign bodies are surrounded by a green ring.
Dosage forms
- Eye drops
Formulation
COMBINATION PREPARATIONS
Lidocaine/ Fluorescein
Eye drops (per 0.5ml) 20mg/1.25mg
- Minims Lidocaine & Fluorescein (Bausch & Lomb) originator
References
1. https://drive.google.com/drive/folders/1UfU0mqV6jj432mWTWcLyJ9AsohqrSMF3 (Mims_08/06/2017_iNova_Lidocaine&Fluorescein_sol) 2. https://www.medicines.org.uk/emc/medicine/16962 (29/07/2015_B&L_Minims Lidocaine&Fluorescein_drops) 3. https://www.medicines.org.uk/emc/medicine/20208 (Fluorescein SPC) 4. https://drive.google.com/drive/folders/1UfU0mqV6jj432mWTWcLyJ9AsohqrSMF3 (31/12/1978_Minims_Lidocaine&Fluorescein)
Brands & products
1 product · cached snapshot- Minims Lidocaine & Fluorescein
OPDEye drops· 1 product
from R487.84| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Minims Lidocaine and Fluorescein | 20 mg/0.5ml;mg/0.5 ml | 0.5 | Soflens (Pty) Ltd | R487.84 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.